These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 15459524

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Postmenopausal hormone replacement therapy and cardiovascular risk: role of conjugated equine estrogens and medroxyprogesterone acetate].
    Ortmann J, Traupe T, Vetter W, Barton M.
    Praxis (Bern 1994); 2004 May 19; 93(21):904-14. PubMed ID: 15216975
    [Abstract] [Full Text] [Related]

  • 3. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
    Lippert TH, Mueck AO.
    MMW Fortschr Med; 2003 Sep 11; 145(37):13; author reply 13-4. PubMed ID: 14584434
    [No Abstract] [Full Text] [Related]

  • 4. Does postmenopausal hormone therapy cause urinary incontinence?
    Rivera R, Gousse A.
    Nat Clin Pract Urol; 2006 Jun 11; 3(6):304-5. PubMed ID: 16763639
    [No Abstract] [Full Text] [Related]

  • 5. Women's health. The vanishing promises of hormone replacement.
    Enserink M.
    Science; 2002 Jul 19; 297(5580):325-6. PubMed ID: 12130763
    [No Abstract] [Full Text] [Related]

  • 6. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Pines A, Sturdee D.
    Ann Intern Med; 2010 Jul 06; 153(1):61; author reply 61-2. PubMed ID: 20621912
    [No Abstract] [Full Text] [Related]

  • 7. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Sullivan JL.
    Ann Intern Med; 2010 Jul 06; 153(1):61; author reply 61-2. PubMed ID: 20621911
    [No Abstract] [Full Text] [Related]

  • 8. Menopausal hormone therapy and risk for cardiovascular disease in the WHI trial.
    Harman SM, Brinton EA, Naftolin F, Merriam GR, Cedars MI, Freeman RG, Santoro N.
    Ann Intern Med; 2010 Jul 06; 153(1):60-1; author reply 61-2. PubMed ID: 20621909
    [No Abstract] [Full Text] [Related]

  • 9. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE.
    MMW Fortschr Med; 2004 Feb 26; 146(9):26-8, 30. PubMed ID: 15352702
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of estrogen plus progestin on knee symptoms and related disability in postmenopausal women: The Heart and Estrogen/Progestin Replacement Study, a randomized, double-blind, placebo-controlled trial.
    Nevitt MC, Felson DT, Williams EN, Grady D.
    Arthritis Rheum; 2001 Apr 26; 44(4):811-8. PubMed ID: 11315920
    [Abstract] [Full Text] [Related]

  • 14. Cardiovascular and metabolic effects of medroxyprogesterone acetate versus conjugated equine estrogen after premenopausal hysterectomy with bilateral ovariectomy.
    Kalyan S, Hitchcock CL, Sirrs S, Pudek M, Prior JC.
    Pharmacotherapy; 2010 May 26; 30(5):442-52. PubMed ID: 20411996
    [Abstract] [Full Text] [Related]

  • 15. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN.
    Acta Obstet Gynecol Scand; 2004 Jul 26; 83(7):661-6. PubMed ID: 15225192
    [Abstract] [Full Text] [Related]

  • 16. New information about hormone therapy and cardiovascular disease prevention in women.
    Goldie MP.
    Int J Dent Hyg; 2007 Aug 26; 5(3):190-3. PubMed ID: 17615030
    [No Abstract] [Full Text] [Related]

  • 17. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD.
    Am J Epidemiol; 2009 Mar 15; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
    Herrington DM, Reboussin DM, Brosnihan KB, Sharp PC, Shumaker SA, Snyder TE, Furberg CD, Kowalchuk GJ, Stuckey TD, Rogers WJ, Givens DH, Waters D.
    N Engl J Med; 2000 Aug 24; 343(8):522-9. PubMed ID: 10954759
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.